The Faravahar Heme-Onc Alliance (FHOA) is a global nonprofit, cultural, and scientific organization founded to connect Persian hematology and oncology professionals around the world. Our vision is to create a unified global community of Persian physicians, scientists, and healthcare leaders working together to advance cancer medicine, improve patient outcomes, and strengthen cultural and humanitarian ties across borders. We believe that Persian heritage, compassion, and scientific excellence can together create a bridge between modern medicine and timeless human values.
The mission of FHOA is threefold:
The Faravahar Heme-Onc Alliance welcomes all Persian and Persian-affiliated healthcare professionals, trainees, and researchers in hematology and oncology. Membership is free for medical students, residents, and fellows, with annual dues for practicing physicians and scientists to support educational and humanitarian programs.
Members gain access to:
Director of Long-Term Transplant Clinic
Visionary Behind the Alliance Mission
Director of Research & Innovation
Director of Multiple Myeloma Section
Board Member & Scientific Advisor
Director, Long-Term Transplant Clinic
Sarah Cannon Transplant and Cellular Therapy Program – Methodist Hospital, San Antonio, Texas
Hematology and Oncology
Dr. Behyar Zoghi, MD, PhD, FACP
Founder of FHOA
Dr. Behyar Zoghi is a physician-scientist, educator, and visionary founder of the Faravahar Heme-Onc Alliance, recognized for advancing cellular therapy, transplant survivorship, and graft-versus-host disease (GVHD) management. His groundbreaking contribution to the ROCKstar trial, which established belumosudil as a treatment option for chronic GVHD, helped transform post-transplant care worldwide.
During his fellowship, Dr. Zoghi conducted pioneering research on microRNA as a novel therapeutic strategy for chemotherapy-resistant breast cancer, earning a patent for his discovery and receiving the Texas Society of Clinical Oncology Award. A lifelong scholar, his PhD work focused on molecular signaling in cancer metabolism, emphasizing angiogenesis and tyrosine kinase pathways. He is triple board-certified and re-certified in Internal Medicine, Hematology, and Medical Oncology.
As Director of the Long-Term Transplant Clinic within the Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital San Antonio, Dr. Zoghi leads a multidisciplinary team dedicated to advancing recovery, immune reconstitution, and long-term quality of life after cellular and bone marrow transplantation. He holds academic appointments at the University of Texas Health Science Center at San Antonio and the University of the Incarnate Word School of Medicine, where he has mentored and inspired medical students and trainees for over a decade.
His accomplishments have been recognized through honors including Castle Connolly Top Doctor, Texas Super Doctor, the ACP Early Career Physician Leader Award, and the Cancer Prevention Research Institute of Texas Grant Award. He is a Fellow of the American College of Physicians (FACP) and an active member of ASTCT, ASH, ASCO, and EHA.
Dr. Zoghi is from Dombelid Taleghan, a valley cradled in the arms of the Alborz Mountains, where the air is clear, the rivers speak, and the people carry both humility and mountain pride. Taleghan is not merely a place—it is a spirit of endurance, wisdom, and light. It is the land where dawn touches the snow peaks of Alborz, where every spring sings of freedom, and where each child learns courage, kindness, and truth.
“I love the concept of treating both the body and the soul. Science, medicine, and faith are like the two wings of a bird—only by using both can we truly soar. I believe that the power of Ahura Mazda and the Faravahar on one side, and the science of hematology and oncology on the other, together illuminate the path toward healing and extend the light of the universe. By honoring and incorporating each patient’s spiritual beliefs as a source of strength, we can harmonize faith and medicine to guide compassionate, holistic, and transformative cancer care.”
Outside of medicine, Dr. Zoghi’s intellectual passions include history, politics, and Persian mythology, fields that deepen his understanding of civilization, leadership, and the timeless connection between knowledge, justice, and the human spirit.
Dr. Zoghi’s academic and research work spans translational science, immunotherapy, and stem-cell biology. He has contributed to national and international clinical trials in areas such as:
His publications and clinical trials have helped shape modern standards in transplant care and immune reconstitution.
Beyond medicine, Dr. Zoghi is a humanitarian deeply committed to improving access to healthcare for underserved populations. He provides telemedicine services to more than 700 patients daily in rural villages near his hometown of Donbelid, Taleghan (Iran), offering free consultations and medical care.
He serves on the Advisory Board of HeartsNeedArt, a nonprofit organization that integrates art, music, and meditation into the healing process for cancer patients, and is an active member of the World Affairs Council of San Antonio.
“The Faravahar Heme-Onc Alliance is more than a professional network — it is a bridge between Persian physicians, scientists, and healers around the world. We are united not only by our shared science but by a shared soul — the belief that knowledge, compassion, and culture together can heal.”
Under Dr. Zoghi’s leadership, the FHOA stands as a beacon for:
Hematologist & medical oncologist; Director of Research & Innovation at Sarah Cannon Adult Stem Cell & Cellular Therapy Program, Methodist Hospital, San Antonio. Leads scientific collaboration and innovation.
Dr. Nosha Farhadfar, MD
President & Director Of FHOA
Dr. Nosha Farhadfar serves as Director of Research and Innovation at the Sarah Cannon Adult Stem Cell and Cellular Therapy Program. Her work integrates scientific discovery with compassionate care, guiding the Alliance’s global initiatives in education, innovation, and international research collaboration.
Dr. Farhadfar is deeply committed to mentoring young Persian physicians and advancing innovation in cellular therapy to improve the lives of patients worldwide.
Hematologist & Medical Oncologist
Subspecialty Training in Bone Marrow Transplantation
Dr. Amin Firoozmand, MD
Board Member & Scientific Advisor Of FHOA
Dr. Amin Firoozmand is a U.S. board-certified hematologist and medical oncologist with advanced training in bone marrow transplantation. He completed a postdoctoral research fellowship at Johns Hopkins Hospital, where he worked under Nobel Laureate Dr. Gregg Semenza on stem-cell and angiogenesis biology.
Dr. Firoozmand has held academic and leadership positions in the U.S. and abroad, including Assistant Professor of Medicine at the Seidman Comprehensive Cancer Center.
He currently practices at the Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital in San Antonio, Texas.
The Faravahar Heme-Onc Alliance envisions a vibrant, united network of Persian physicians and scientists collaborating to:
Through shared purpose, professionalism, and pride in heritage, FHOA stands as a symbol of scientific excellence and humanitarian connection across the global Persian medical community.
Membership in FHOA is open to all Persian and Persian-affiliated professionals in hematology and oncology.
“whether You Are A Student Beginning Your Journey Or A Senior Physician Shaping The Field, The Faravahar Heme-onc Alliance Offers A Community Rooted In Persian Identity, Global Science, And Service.”
Nonprofit Status: Application for 501(c)(3) recognition has been submitted, EIN obtained in the State of Texas.
Bylaws: The governing document of the Alliance, ensuring transparency, accountability, and alignment with the mission. Articles include:
The Faravahar Heme-onc Alliance (Fhoa) Is Structured As A Nonprofit, Charitable, And Educational Organization.
